Frank A. Bucci, Jr., M.D.
Closed portfolio with a later-stage archive tilt
According to ClinicalTrials.gov-derived indexes, Frank A. Bucci, Jr., M.D. sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
Frank A. Bucci, Jr., M.D.: 4 sponsored US clinical trials, none currently recruiting.
Frank A. Bucci, Jr., M.D. sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 4 completed. 3 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cataracts, with 2 trials.
Upper-quartile sponsor footprint
Frank A. Bucci, Jr., M.D. sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Pharmacokinetics of Aqueous Dexamethasone
NCT04667507
Aqueous Absorption and Pharmacokinetics of Besivance Versus VIGAMOX in Patients Undergoing Phacoemulsification
NCT01296191
Evaluation the TECNIS IOL in Both Eyes VS the ReZoom IOL in One and TECNIS IOL in the Opposite
NCT01253239
A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification
NCT01001806
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 3 |
Therapeutic Areas
How the Frank A. Bucci, Jr., M.D. archive is shaped
4 indexed studies, none listed as recruiting (0% open); 4 completed (100%).
Phase mix: 3 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Cataracts (2 trials), 3 others listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
Frank A. Bucci, Jr., M.D.: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
Frank A. Bucci, Jr., M.D. sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this Frank A. Bucci, Jr., M.D. page
4 registered trials is a research-attention snapshot, not an endorsement of Frank A. Bucci, Jr., M.D. or any single study.
- None of Frank A. Bucci, Jr., M.D.'s trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Cataracts is the condition Frank A. Bucci, Jr., M.D. studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cataracts trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Frank A. Bucci, Jr., M.D. pipeline card: 4 registered trials from official public datasets.Report a data error.